✦
UWELL CLOUD YOU JIAN YUN

Ruijin Hospital Hainan Branch

RAK-cell therapy after liver cancer surgery

Therapy using a patient’s own RAK cells after surgery for hepatocellular carcinoma, a type of liver cancer.

Historical anatomical illustration: underside of the liver · Colourized electron micrograph of a T lymphocyte
Historical anatomical illustration · Research microscopy · Image credits

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

Clinical details below are in English. Ask the care team for help understanding the source documents.

What to clarify

This is described as an autologous cell intervention after liver-cancer surgery. Autologous means derived from the patient; it does not identify the cell phenotype, activation method or evidence. The clinical question is how any added intervention fits with postoperative surveillance and other indicated care.

Before your consultation

Surgical pathology and margin report; operation date; liver function; hepatitis history; current imaging.

Use existing documents for the initial inquiry. The hospital should specify whether additional tests are needed after reviewing them. Arrange secure transfer of records through the care team; do not place sensitive records in a public message.

Evidence and limitations

The supplied price tables identify a named intervention and hospital, but contain no study reference, detailed safety information or patient-specific recommendation. They cannot establish current authorization, benefit, eligibility or availability. Ask for the exact product or cell preparation, the applicable clinical or research pathway and the consent information.

If offered as research, request the registry identifier, study phase, eligibility criteria, sponsor and follow-up obligations. A trial registration is a record of a study; it is not a guarantee that the intervention works.

Questions to ask

Does this replace postoperative surveillance?

Ask the liver-cancer team how any proposed cell intervention relates to the surveillance and other care recommended after surgery. A price-table entry does not show that recurrence will be prevented.

What needs to be confirmed before I travel?

Obtain a clinical review of your documents, the exact proposed intervention, a written quotation, expected visits and a named contact for follow-up. Ask what happens if the in-person assessment changes the plan.

Price and quotation

Source reference price

CNY 45,000≈ USD 6,720Per administration

Ruijin Hospital Hainan Branch

Request a current quotation
Review the source

Source document undated

Original source notation: 4.5万/次

Approximate conversion ·
Central Bank of the UAE · exchange rates

A reference amount is not a total course price. Ask the provider to itemize assessment, testing, cell or product preparation, administration, admission, medicines and follow-up where applicable. Confirm the number of sessions, currency, quote validity and refund or cancellation terms. Accommodation, travel and Uwell coordination are separate unless the written quotation says otherwise.

Sources and editorial scope

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.

Original catalogue entries

Source publication date: not supplied. The figures remain source references rather than a current hospital quotation.

Reference catalogue
Sariyah Ahmad
Active Triage Officer

Welcome to Uwell Cloud. Connecting from Malaysia, Indonesia, or Thailand? Ask me about visa-free travel and stem cell medical programs in Boao Lecheng.